PBR Antibodies

Santa Cruz Biotechnology features a diverse variety of PBR Antibodies for the specific detection and analysis of the peripheral benzodiazepine receptor (PBR). PBR Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The peripheral benzodiazepine receptor plays a crucial role in cellular functions such as steroidogenesis, apoptosis, and the regulation of mitochondrial function. PBR's involvement in neuroinflammation and neuroprotection makes it a significant target in both physiological and pathological processes. Research focusing on PBR has revealed its importance in various diseases, including neurodegenerative disorders and cancer. Scientists worldwide are actively investigating PBR's molecular mechanisms and potential therapeutic applications. Ongoing studies continue to uncover new aspects of PBR's role in cellular signaling and disease progression. Understanding PBR's function and regulation could lead to breakthrough therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential treatments for PBR-related conditions.